Related Experiment Video
Updated: Dec 30, 2025
10:01
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
7.8K
Current multidisciplinary management of brain metastases
Michael J Moravan1,2, Peter E Fecci3, Carey K Anders4
1Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Cancer
|January 24, 2020
Summary
Brain metastasis (BM) management is complex due to new therapies. Optimal treatment requires multidisciplinary discussion, focusing on quality of life and neurocognition for improved survival.
Area of Science:
- Neuro-oncology
- Cancer Metastasis
- Clinical Oncology
Background:
- Brain metastasis (BM) is the most common adult brain tumor, affecting 20-40% of late-stage cancer patients.
- BM traditionally carries a poor prognosis, but survival rates are improving.
- Management is complex due to advances in systemic therapies, radiation oncology, and neurosurgery.
Purpose of the Study:
- To review current and emerging treatment options for brain metastasis.
- To provide approaches for managing treatment sequelae and disease recurrence.
- To emphasize individualized patient care and multidisciplinary decision-making.
Main Methods:
- Review of current therapeutic modalities for BM.
- Discussion of novel and investigational treatments.
- Analysis of strategies for managing adverse effects and recurrence.
Main Results:
- A wide array of treatments are available, including stereotactic radiosurgery, radiation therapy, surgery, and systemic agents.
- Emerging therapies include targeted agents and immune-checkpoint inhibitors.
- Individualized treatment plans are crucial for optimizing outcomes.
Conclusions:
- The management of BM necessitates a multidisciplinary approach.
- Addressing sequelae and maintaining quality of life are paramount.
- Improved survival highlights the need for comprehensive BM care strategies.
